PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
25019556-6	2014	A total of three potential inhibitors of SFRP4 were found, namely cyclothiazide, clopamide and perindopril.	Clopamide	81-90	secreted frizzled related protein 4	Homo sapiens	41-46
25019556-8	2014	The findings suggest the possible treatment of diabetes mellitus type 2 by inhibiting the SFRP4 using the inhibitors cyclothiazide, clopamide and perindopril.	Clopamide	132-141	secreted frizzled related protein 4	Homo sapiens	90-95
2682268-3	1989	The venoconstrictor response to bradykinin was attenuated after oral administration of both the thiazide-like diuretic clopamide (0.5 mg/kg) or cyclosporine-A (30 mg/kg), and by concomitant local infusion of cyclosporine-A (1-10 micrograms/min).	Clopamide	119-128	kininogen 1	Canis lupus familiaris	32-42
2682268-5	1989	infusion of the renin inhibitor H-77 (0.1 mg/kg/h) reversed the inhibition of bradykinin by both clopamide and cyclosporine-A.	Clopamide	97-106	renin	Canis lupus familiaris	16-21
2682268-5	1989	infusion of the renin inhibitor H-77 (0.1 mg/kg/h) reversed the inhibition of bradykinin by both clopamide and cyclosporine-A.	Clopamide	97-106	kininogen 1	Canis lupus familiaris	78-88
6137325-6	1983	Increases in LDL-C caused by chlorthalidone monotherapy were prevented or reversed by the addition of a beta-blocker, usually propranolol or atenolol (n = 18); increases in LDL-C during clopamide monotherapy were reversed after the addition of the beta-blocker pindolol (10 mg/day, n = 17).	Clopamide	186-195	component of oligomeric golgi complex 2	Homo sapiens	173-178
5064563-0	1972	[Effect of clopamide and ethacrynic acid on renin secretion in the dog].	Clopamide	11-20	renin	Canis lupus familiaris	44-49
7043175-2	1982	Compared to placebo conditions, clopamide monotherapy significantly increased serum low-density lipoprotein cholesterol (LDL-C) by 13% (p less than 0.025).	Clopamide	32-41	component of oligomeric golgi complex 2	Homo sapiens	84-119
7043175-2	1982	Compared to placebo conditions, clopamide monotherapy significantly increased serum low-density lipoprotein cholesterol (LDL-C) by 13% (p less than 0.025).	Clopamide	32-41	component of oligomeric golgi complex 2	Homo sapiens	121-126
7043175-6	1982	These findings suggest that antihypertensive combination treatment with low doses of clopamide and pindolol is not only effective and well tolerated, but may also avoid the increase in serum LDL-C levels occurring when the thiazide-like diuretic is given alone.	Clopamide	85-94	component of oligomeric golgi complex 2	Homo sapiens	191-196
6032108-0	1967	The effects of a substituted sulphamoyl diuretic "clopamide" (DT 327) on insulin release in vitro.	Clopamide	50-59	insulin	Homo sapiens	73-80